Bibliography
- Caruthers SD , WicklineSA, LanzaGM: Nanotechnological applications in medicine.Curr. Op. Biotech.18, 26–30 (2007).
- Heath JR , DavisME: Nanotechnology and cancer.Ann. Rev. Med.59, 251–265 (2008).
- Nasongkla N , BeyE, RenJet al.: Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.Nano. Lett.6, 2427–2430 (2006).
- Arruebo M , Fernández-PachecoR, IbarraMR, SantamariaJ: Magnetic nanoparticles for drug delivery.Nano. Today2, 22–32 (2007).
- Lin MM , KimHH, DobsonJ, Kim do K: Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine5, 109–133 (2010).
- Laurent S , BoutryS, MahieuI, VanderElstL, MullerRN: Iron oxide based contrast agents: from chemistry to cell labeling.Curr. Med. Chem.16, 4712–4727 (2009).
- Qiang Y , AntonyJ, SharmaA, NuttingJ, SikesD, MeyerD: Iron/iron oxide core-shell nanoclusters for biomedical applications.J. Nanopart. Res.8, 489–496 (2006).
- Alexiou C , SchmidRJ, JurgonsRet al.: Targeting cancer cells: magnetic nanoparticles as drug carriers.Eur. Biophys. J.35, 446–450 (2006).
- Cengelli F , MaysingerD, Tschuddi-MonnetFet al.: Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.J. Pharm. Exp. Therap.318, 108–116 (2006).
- Hanessian S , GrzybJA, CengelliF, Juillerat-JeanneretL: Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs.Bioorg. Med. Chem.16, 2921–2931 (2008).
- Cengelli F , GrzybJA, MontoroA, HofmannH, HanessianS, Juillerat-JeanneretL: Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.Chem. Med. Chem.4, 988–997 (2009).
- Kohler N , SunC, WangJ, ZhangM: Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.Langmuir21, 8858–8864 (2005).
- Kohler N , SunC, FichtenholtzA, GunnJ, FangC, ZhangM: Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.Small2, 785–792 (2006).
- Lee PW , HsuSH, WangJJet al.: The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.Biomaterials31, 1316–1324 (2010).
- Mailänder V , LandfesterK: Interaction of nanoparticles with cells.Biomacromolecules14, 2379–2400 (2009).
- Petri-Fink A , HofmannH: Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies.IEEE Trans. Nanobioscience6, 289–297 (2007).
- Petri-Fink A , ChastellainM, Juillerat-JeanneretL, FerrariA, HofmannH: Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.Biomaterials26, 2685–2694 (2005).
- Petri-Fink A , SteitzB, FinkaA, SalaklangJ, HofmannH: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.Eur. J. Pharm. Biopharm.68, 129–137 (2008).
- Al-Amoudi A , NorlenLPO, DubochetJ: Cryo-electron microscopy of vitreous sections of native biological cells and tissues.J. Struct. Biol.148, 131–135 (2004).
- Al-Amoudi A , ChangJJ, LeforestierAet al.: Cryo-electron microscopy of vitreous sections.EMBO J.23, 3583–3588 (2004).
- Ge Y , ZhangY, XiaJet al.: Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.Colloids Surfaces B. Biointerferences73, 294–301 (2009).
- Soenen SJH , De Cuyper M: Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol. Imaging4, 207–219 (2009).
- Hongtao LV , ZhangS, WangB, CuiS, YanJ: Toxicity of cationic lipids and cationic polymers in gene delivery.J. Control Rel.114, 100–109 (2006).
- Doherty GJ , McMahonHT: Mechanisms of endocytosis.Ann. Rev. Biochem.78, 857–902 (2009).
- Schulze E , FerrucciJT, PossK, LapointeL, BogdanovaA, WeisslederR: Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro.Invest. Radiol.30, 604–610 (1995).
- Schulze K , KochA, Petri-FinkAet al.: Uptake and biocompatibility of functionalized poly(vinylalcohol) coated superparamagnetic maghemite nanoparticles by synoviocytes in vitro.J. Nanosci. Nanotechnol.6, 2829–2840 (2006).
- Conner SD , SchmidSL: Regulated portals of entry into the cell.Nature422, 37–44 (2003).
- Gong Q , HuntsmanC, MaD: Clathrin-independent internalization and recycling.J. Cell. Mol. Med.12, 126–144 (2008).
- Vercauteren D , VandenbrouckeRE, JonesATet al.: The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls.Mol. Therap.18, 561–569 (2010).
- Soenen SJH , VercauterenD, BraeckmansK, NoppeW, De Smedt S, De Cuyper M: Stable long-term intracellular labeling with fluorescently tagged cationic magnetoliposomes. Chem. Bio. Chem.10, 257–267 (2009).
- Anas A , OkudaT, KawashimaNet al.: Clathrin-mediated endocytosis of quantum dot–peptide conjugates in living cells.ACS Nano3, 2419–2429 (2009).
- Harush-Frenkel O , DebottonN, BenitaS, AltschulerY: Targeting of nanoparticles to the clathrin-mediated endocytic pathway.Biochem. Biophys. Res. Comm.353, 26–32 (2007).
- Rejman J , OberleV, ZuhornIS, HoekstraD: Size-dependent internalization of particles via the pathway of clathrin- and caveolae-mediated endocytosis.Biochem. J.377, 159–169 (2004).
- Minarowska A , MinarowskiL, KarwowskaA, GackoM: Regulatory role of cathepsin D in apoptosis.Folia Histochem. Cytobiol.45, 159–163 (2007).
- Arbab AS , WilsonLB, AshariP, JordanEK, LewisBK, FrankJA: A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.NMR Biomed.18, 383–389 (2005).
- Huang DM , HsiaoJK, ChenYCet al.: The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.Biomaterials30, 3645–3651 (2009).
- Aisen P : Tranferrin receptor 1.Int. J. Biochem. Cell. Biol.36, 2137–2143 (2004).
- Beutler E : Iron storage disease: facts, fiction and progress.Blood Cells Mol. Dis.39, 140–147 (2007).
- Rouault TA : The role of iron regulatory proteins in mammalian iron homeostasis an disease.Nat. Chem. Biol.2, 406–414 (2006).
- Schäffer R , KehlbachR, WiskirchenJet al.: Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.Radiology244, 514–523 (2007).
- Poncet S , MeyerS, RichardC, AubertJD, Juillerat-JeanneretL: The expression and function of the endothelin system in contractile properties of vaginal myofibroblasts of women with utero–vaginal prolapse.Am. J. Obst. Gynecol.192, 426–432 (2005).
- Hendrix MJ , SeftorEA, HessAR, SeftorRE: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.Nature Rev. Cancer3, 411–421 (2003).
- Zhang S , ZhangD, SunB: Vasculogenic mimicry: current status and future prospects.Cancer Lett.254, 157–164 (2007).